THEMISMED SHARE PRICE PREDICTION
Recommendation → Expensive Star
- Week
- Month
- 3 Month
- Year
Open |
280.00
|
High |
280.00
|
Low |
275.85
|
52-Wk High |
303.00
|
52-Wk Low |
142.00
|
Interpretation of Candlestick Chart
Hanging Man Considering these factors, the current market outlook for THEMISMED suggests a challenging environment for buyers, with the potential for further downside movement in the short term.
THEMISMED Share price Prediction:-
Period | Target 1 | Target 2 |
---|---|---|
2024 | 143.42 | 303.01 |
2025 | 225.42 | 385.01 |
2026 | 307.42 | 467.01 |
2027 | 389.42 | 549.01 |
2028 | 471.42 | 631.01 |
2029 | 553.42 | 713.01 |
2030 | 635.42 | 795.01 |
2031 | 717.42 | 877.01 |
2032 | 799.42 | 959.01 |
2033 | 881.42 | 1041.01 |
2034 | 963.42 | 1123.01 |
THEMISMED share price target 2024 to 2034 :-
THEMISMED’s share price target is the estimated value of the stock at a given point in time. It is based on our research, history, fundamentals, market trends and other factors.
2024
The minimum share price target for THEMISMED shares is Rs 143.42 and the maximum
target
price is Rs 303.01 by 2024
- Target1 : 143.42
- Target 2 : 303.01
2025
The minimum share price target for THEMISMED shares is Rs 225.42 and the
maximum target price is Rs 385.01 by
2025
- Target1 : 225.42
- Target 2 : 385.01
2026
The minimum share price target for THEMISMED shares is Rs 307.42 and the
maximum target price is Rs 467.01 by
2026
- Target1 : 307.42
- Target 2 : 467.01
2027
The minimum share price target for THEMISMED shares is Rs 389.42 and the
maximum target price is Rs 549.01 by
2027
- Target1 : 389.42
- Target 2 : 549.01
2028
The minimum share price target for THEMISMED shares is Rs 471.42 and the
maximum target price is Rs 631.01 by
2028
- Target1 : 471.42
- Target 2 : 631.01
2029
The minimum share price target for THEMISMED shares is Rs 553.42 and the
maximum target price is Rs 713.01 by
2029
- Target1 : 553.42
- Target 2 : 713.01
2030
The minimum share price target for THEMISMED shares is Rs 635.42 and the
maximum target price is Rs 795.01 by
2030
- Target1 : 635.42
- Target 2 : 795.01
2031
The minimum share price target for THEMISMED shares is Rs 717.42 and the
maximum target price is Rs 877.01 by
2031
- Target1 : 717.42
- Target 2 : 877.01
2032
The minimum share price target for THEMISMED shares is Rs 799.42 and the
maximum target price is Rs 959.01 by
2032
- Target1 : 799.42
- Target 2 : 959.01
2033
The minimum share price target for THEMISMED shares is Rs 881.42 and the
maximum target price is Rs 1041.01 by
2033
- Target1 : 881.42
- Target 2 : 1041.01
2034
The minimum share price target for THEMISMED shares is Rs 963.42 and the
maximum target price is Rs 1123.01 by
2034
- Target1 : 963.42
- Target 2 : 1123.01
**THEMISMED share price target prediction for 2024, 2025, and 2026 through 2034 is based on growth assumptions, future forecasts, and the existing state of the market. It is subject to change dependent on market sentiment.
THEMISMED Past Performance:-
1 Day →
1 Week →
1 Month →
3 Month →
1 Year →
Simple Moving Average (SMA) of THEMISMED :-
SMA 5 → 262.79
SMA 34 → 271.90
SMA 20 → 268.47
SMA 13 → 268.33
SMA 89 → 266.17
SMA 200 → 234.26
Exponential Moving Average (EMA) of THEMISMED :-
EMA 5 → 261.50
EMA 34 → 266.41
EMA 20 → 267.21
EMA 13 → 265.89
EMA 89 → 263.18
EMA 200 → 232.70
Bollinger Band THEMISMED :-
BBand Upper → 282.52
BBand Lower → 254.42
BBand Mid → 268.47
Moving Average Convergence THEMISMED :-
MACD →
MACD Signal →
MACD Hist →
Past Performance
THEMISMED Change in 1 day
0.82%
Change in 1 day
THEMISMED Change in 1 Week
-4.68%
Change in 1 Week
THEMISMED Change in 1 Month
-5.34%
Change in 1 Month
THEMISMED Change in 3 Month
0.71%
Change in 3 Month
THEMISMED Change in 1 Year
65.19%
Change in 1 Year
What is the current share price of THEMISMED ?
What is the target of THEMISMED tomorrow?
What is the full form of THEMISMED ?
Can I invest in THEMISMED share?
Is THEMISMED a buy hold or sell?
Durability : 1.12
Valuation : 0.13
Momentum : 84.47
Therefore, as per risk appetite of the investor whether to buy hold or sell the THEMISMED at current level.